Gliclazide, a KATP channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ-AMPK pathway (Q50033960)

23 February 2018

title

Gliclazide, a KATP channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ-AMPK pathway (English)

1 reference

23 February 2018

1 reference

Kyung Young Lee

1 reference

23 February 2018

Jae-Ryong Kim

series ordinal

1 reference

23 February 2018

Hyoung Chul Choi

series ordinal

1 reference

23 February 2018

publication date

11 January 2018

1 reference

23 February 2018

published in

Vascular Pharmacology

1 reference

23 February 2018

Treating diabetes today with gliclazide MR: a matter of numbers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Role of KATP channels in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Serine-385 phosphorylation of inwardly rectifying K+ channel subunit (Kir6.2) by AMP-dependent protein kinase plays a key role in rosiglitazone-induced closure of the K(ATP) channel and insulin secretion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Kir6.2-containing ATP-sensitive K(+) channel is required for cardioprotection of resveratrol in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Antagonists of the TMEM16A calcium-activated chloride channel modulate airway smooth muscle tone and intracellular calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Characterization of the CaMKKβ-AMPK signaling complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Oral hypoglycemic sulfonylurea glimepiride preserves the myoprotective effects of ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Losartan Inhibits Vascular Smooth Muscle Cell Proliferation through Activation of AMP-Activated Protein Kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Diabetes and insulin secretion: the ATP-sensitive K+ channel (K ATP) connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Physiological roles of K+ channels in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Gliclazide inhibits proliferation but stimulates differentiation of white and brown adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Effects of sulfonylureas on tumor growth: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Sulfonylurea stimulation of insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Leptin promotes K(ATP) channel trafficking by AMPK signaling in pancreatic β-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

ATP and sulfonylurea linkage in the K(ATP) channel solves a diabetes puzzler

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Glibenclamide exerts an antitumor activity through reactive oxygen species-c-jun NH2-terminal kinase pathway in human gastric cancer cell line MGC-803.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Do the K+ channel openers relax smooth muscle by opening K+ channels?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Inhibition of tumor cell proliferation by sigma ligands is associated with K+ Channel inhibition and p27kip1 accumulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

AMP-activated protein kinase connects cellular energy metabolism to KATP channel function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2018.01.001

10.1016/J.VPH.2018.01.001

7 January 2021

Identifiers

DOI

1 reference

23 February 2018

1 reference

23 February 2018